Artificial intelligence (AI) and AI-enabled devices are already making their way into the market and should be able to help make meaning of data in order to improve care delivery, said speakers at the 15th Annual World Health Care Congress.
Already, artificial intelligence (AI) is starting to spread into healthcare with AI-enabled devices. During a session at the 15th Annual World Health Care Congress, Mark H. Michalski, MD, executive director of MGH & BWH Center for Clinical Data Science, a collaboration by Massachusetts General Hospital and Brigham and Women's Hospital, and Tom McGuinness, chief strategy and commercial officer at GE Healthcare, discussed how AI can be used to advance care.
Diagnostics, radiology, and pathology were the first parts of healthcare to really embrace AI technology, according to Michalski. The technology allows the healthcare industry to do the work faster and add value to the final report. He is also excited for what comes next that AI can assist with, such as finding novel biomarkers or building patient cohorts throughout the entire medical system.
McGuinness added that AI has the potential to make sense of the deluge of data in the healthcare system, which is slowing down decision making and making it a challenge to create a holistic 360-degree view of a patient.
“Big data and AI really go hand in glove,” he said. AI thrives in data-rich environments, and the more data you throw at an AI algorithm, the smarter it becomes.
“Why artificial intelligence is so useful is we’ve got this big boatload of data we don’t know what to do with,” but once you apply AI to it, you can start to suss out meaning from it all, Michalski agreed.
Eventually, AI will be one of the many tools at a physician’s disposal to create value. It will help to find disconnects and create efficiencies. He provided the example of looking at the number of errors taking place in radiography. Big data can allow someone to look at the errors in a retrospective analysis and identify the drivers afterward, but AI allows you to bring the information to the front at the time of decision making so clinicians can understand the errors, predict them, and prevent them.
The challenge with such novel technology is regulating it, because systems using AI can adapt and change over time. As the systems adapt and change, how will FDA apply standards that were meant for systems that were built to never change?
“How do those paradigms for regulation evolve?” asked Michalski.
McGuinness agreed. When things are regulated, they get tested and locked, he explained, but that’s not the nature of AI. “The inherent nature of artificial intelligence is that it moves forward.”
Both speakers also agreed that AI will never replace the clinical assessment of a provider after the moderator questioned whether the use of AI will lead to the loss of unspoken indications, such as when a patient comes in with bruises and says he or she fell, but the expression signs seen by the clinician indicate that there is abuse.
McGuinness stressed that AI will complement and augment the work of clinicians. Michalski added that once there is an algorithm to help make meaning of data, providers can determine if they’re losing something and figure out a different way to capture that additional information.
Finally, they spoke about how they think AI will impact healthcare in the short term. Michalski hopes that AI will change the way providers interact with data so that the most important data is highlighted for them to act on.
McGuinness added that some AI is already out in the market and impacting healthcare, but that it’s just in the beginning stages.
“As we demonstrate the value of these, there will be more proliferation of [AI] as a tool,” he said.
Race/Ethnicity May Influence Local Recurrence in DCIS, Adjuvant Treatment
December 6th 2023Disparities in 10-year local recurrence following breast-conserving surgery were seen among women with ductal carcinoma in situ (DCIS) treated over a nearly 4-decade span at Memorial Sloan Kettering Cancer Center, with Black women having the highest rate.
Read More
Emily Goldberg Shares Insights as a Genetic Counselor for Breast Cancer Risk Screening
October 30th 2023On this episode of Managed Care Cast, Emily Goldberg, MS, CGC, a genetic counselor at JScreen, breaks down how genetic screening for breast cancer works and why it is so important to increase awareness and education around these screening tools available to patients who may be at risk for cancer.
Listen
SABCS 2023 Sessions Touch on "Every Aspect of Breast Cancer"
December 4th 2023The 46th annual San Antonio Breast Cancer Symposium will take place December 5-9, with new and experienced attendees able to choose and learn from a schedule overflowing with the latest developments in breast cancer science and research.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
What We’re Reading: ChatGPT in Health Care; Menthol Ban Meeting; Health System Cyberattack Impact
November 30th 2023ChatGPT is changing health care while also raising questions about artificial intelligence's promises and limitations; 24 Biden officials met with the National Organization of Black Law Enforcement Executives to discuss the FDA’s proposal to ban menthol cigarettes; a recent hospital cyberattack shows how the vulnerability of health care systems can put patients at risk.
Read More
Provisional CDC data show that US babies gained roughly a year in life expectancy in 2022; study findings indicate that the COVID-19 pandemic significantly raised the risk of preterm birth for expectant California mothers; New York Attorney General Letitia James said about 4 million New Yorkers were affected by a data breach of the medical transcription company Perry Johnson & Associates.
Read More